← Back to Clinical Trials
Recruiting NCT07399093

NCT07399093 Preoperative Evaluation of IVC Collapsibility Index and Caval Aorta Index After Induction of General Anesthesia

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07399093
Status Recruiting
Phase
Sponsor Ain Shams University
Condition Inferior Vena Cava
Study Type OBSERVATIONAL
Enrollment 36 participants
Start Date 2024-01-14
Primary Completion 2026-03-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 40 Years
Study Type OBSERVATIONAL
Interventions
Inferior vena cava collapsibility indexCaval Aorta Index

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 36 participants in total. It began in 2024-01-14 with a primary completion date of 2026-03-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to assess the accuracy, repeatability, and reproducibility of preoperative evaluation of Inferior Vena Cava (IVC) collapsibility index and caval aorta index for prediction of hypotension after induction of general anesthesia.

Eligibility Criteria

Inclusion Criteria: * Age from 18 to 40 years. * Both sexes. * Body Mass Index\< 40 kg/m². * American Society of Anesthesiologists (ASA) physical status I, II. * Fasted according to the ASA guidelines: 2 hours for clear fluids, 6 hours after light meal, 8 hours after a full meal with high calorie or fat content. * Scheduled for elective craniotomy surgeries before induction of general anesthesia. Exclusion Criteria: * Current or recent pregnancy (within 3 months). * Pre-existing cardiac disease or hypertension. * On medications affecting blood pressure \[Beta-blockers (BBs) and calcium channel blockers (CCBs)\] . * Refusing to undergo the study.

Contact & Investigator

Central Contact

Verina F Zaref, MSc

✉ verina.fares@med.asu.edu.eg

📞 00201098858385

Frequently Asked Questions

Who can join the NCT07399093 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 40 Years, studying Inferior Vena Cava. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07399093 currently recruiting?

Yes, NCT07399093 is actively recruiting participants. Contact the research team at verina.fares@med.asu.edu.eg for enrollment information.

Where is the NCT07399093 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT07399093 clinical trial?

NCT07399093 is sponsored by Ain Shams University. The trial plans to enroll 36 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology